- Home
- / Zhende Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Zhende Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥22.5
2024-10-29
Market Capitalization
¥6.1 B
2024-10-29
Revenue
¥4.2 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.4B | 1.8B | 10.3B | 4.9B | 6.1B | 4.1B | 4.2B |
| Cost of goods sold | 980.7M | 1.3B | 5.5B | 3.3B | 4.0B | 2.7B | 2.8B |
| Gross profit | 431.9M | 586.3M | 4.9B | 1.7B | 2.1B | 1.4B | 1.4B |
| Gross profit margin, % | 34.6% | 34.4% | 33.5% | ||||
| Operating expense total | 222.4M | 333.7M | 1.1B | 736.9M | 1.0B | 770.9M | 786.4M |
| Depreciation and amortization | 63.2M | 74.3M | 132.3M | 226.3M | 189.3M | 313.5M | 243.7M |
| EBITDA | 209.4M | 252.6M | 3.8B | 986.9M | 1.1B | 627.8M | 623.0M |
| EBITDA margin, % | 17.7% | 15.4% | 14.8% | ||||
| EBIT | 182.9M | 228.4M | 3.6B | 810.4M | 863.6M | 191.3M | 446.8M |
| EBIT margin, % | 14.2% | 4.7% | 10.6% | ||||
| Interest income | 1.7M | 1.4M | 12.2M | 15.7M | 10.6M | 40.0M | 24.9M |
| Interest expense | 21.9M | 24.2M | 18.3M | 25.1M | 33.5M | 28.9M | 28.7M |
| Pre tax profit | 151.6M | 199.2M | 3.5B | 819.9M | 801.7M | 218.9M | 475.5M |
| Income tax expense | 21.7M | 22.7M | 561.2M | 99.0M | 100.0M | 5.5M | 78.2M |
| Net Income | 129.9M | 176.6M | 3.0B | 720.9M | 701.8M | 213.4M | 397.2M |